NasdaqGS:GEHCMedical Equipment
FDA-Cleared, Continuously Upgradable AI Platform Might Change The Case For Investing In GE HealthCare (GEHC)
Earlier in June 2026, GE HealthCare received FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, an AI-enabled auto-contouring software that introduces new MR brain and updated CT male pelvis models to streamline radiation therapy planning with minimal user interaction.
A key feature of this clearance is the Predetermined Change Control Plan, which sets up a framework for continuously updating and expanding the software’s AI models across additional anatomical regions and imaging...